Bioxyne Ltd has released a press release.
Appendix 4C - March quarterly
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Bioxyne
- Update On Commercialisation Process
- Appendix 4D - Half Yearly Report and Accounts
- Appendix 4C - December Quarterly
- Mariposa Health Inc. Investment Update
- Bioxyne: Amended Appendix 3Y’s for Adjustment to Directors Share Interests
Later from Bioxyne
- Bioxyne Commences New Clinical Trial
- Appendix 4C - June Quarterly
- Appendix 4E - Preliminary Final Report
- Launch of Two Products Containing PCC Onto Australian Market
- Quarterly Activities and Cash Flow Report Dec 2016
Follow Bioxyne into a list and get an email when it puts out news.
Follow Bioxyne